Name | Number of supported studies | Average coverage | |
---|---|---|---|
type II pneumocyte | 8 studies | 35% ± 20% | |
glutamatergic neuron | 3 studies | 22% ± 4% |
Insufficient scRNA-seq data for expression of ROS1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 97% | 3757.40 | 559 / 578 | 75% | 20.75 | 865 / 1155 |
skin | 50% | 307.60 | 902 / 1809 | 4% | 0.24 | 21 / 472 |
kidney | 43% | 30.78 | 38 / 89 | 2% | 0.13 | 14 / 901 |
intestine | 26% | 23.47 | 252 / 966 | 7% | 0.30 | 36 / 527 |
esophagus | 0% | 0.18 | 6 / 1445 | 28% | 2.12 | 52 / 183 |
stomach | 19% | 9.39 | 67 / 359 | 10% | 0.46 | 29 / 286 |
pancreas | 0% | 0.09 | 1 / 328 | 24% | 1.32 | 43 / 178 |
brain | 21% | 49.15 | 551 / 2642 | 4% | 0.11 | 25 / 705 |
ovary | 1% | 7.25 | 1 / 180 | 16% | 0.73 | 69 / 430 |
uterus | 1% | 0.18 | 1 / 170 | 16% | 0.98 | 72 / 459 |
bladder | 0% | 0 | 0 / 21 | 13% | 2.44 | 65 / 504 |
tonsil | 0% | 0 | 0 / 0 | 11% | 0.40 | 5 / 45 |
liver | 6% | 2.59 | 13 / 226 | 5% | 0.12 | 19 / 406 |
muscle | 6% | 3.37 | 49 / 803 | 0% | 0 | 0 / 0 |
prostate | 4% | 3.62 | 11 / 245 | 2% | 0.02 | 8 / 502 |
breast | 2% | 1.54 | 10 / 459 | 4% | 0.54 | 40 / 1118 |
thymus | 0% | 0.20 | 3 / 653 | 3% | 0.22 | 20 / 605 |
lymph node | 0% | 0 | 0 / 0 | 3% | 0.04 | 1 / 29 |
adipose | 3% | 8.34 | 40 / 1204 | 0% | 0 | 0 / 0 |
adrenal gland | 0% | 0.18 | 1 / 258 | 1% | 0.05 | 3 / 230 |
blood vessel | 1% | 0.73 | 16 / 1335 | 0% | 0 | 0 / 0 |
heart | 1% | 0.49 | 8 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0.36 | 4 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0033674 | Biological process | positive regulation of kinase activity |
GO_0007275 | Biological process | multicellular organism development |
GO_0006468 | Biological process | protein phosphorylation |
GO_0007283 | Biological process | spermatogenesis |
GO_0030154 | Biological process | cell differentiation |
GO_0001558 | Biological process | regulation of cell growth |
GO_0007169 | Biological process | cell surface receptor protein tyrosine kinase signaling pathway |
GO_0032006 | Biological process | regulation of TOR signaling |
GO_0070372 | Biological process | regulation of ERK1 and ERK2 cascade |
GO_0002066 | Biological process | columnar/cuboidal epithelial cell development |
GO_0043235 | Cellular component | receptor complex |
GO_0016020 | Cellular component | membrane |
GO_0005886 | Cellular component | plasma membrane |
GO_0004713 | Molecular function | protein tyrosine kinase activity |
GO_0005524 | Molecular function | ATP binding |
GO_0005515 | Molecular function | protein binding |
GO_0004714 | Molecular function | transmembrane receptor protein tyrosine kinase activity |
GO_0019903 | Molecular function | protein phosphatase binding |
Gene name | ROS1 |
Protein name | Proto-oncogene tyrosine-protein kinase ROS (EC 2.7.10.1) (Proto-oncogene c-Ros) (Proto-oncogene c-Ros-1) (Receptor tyrosine kinase c-ros oncogene 1) (c-Ros receptor tyrosine kinase) ROS proto-oncogene 1, receptor tyrosine kinase Tyrosine-protein kinase receptor (EC 2.7.10.1) |
Synonyms | ROS MCF3 |
Description | FUNCTION: Receptor tyrosine kinase (RTK) that plays a role in epithelial cell differentiation and regionalization of the proximal epididymal epithelium. NELL2 is an endogenous ligand for ROS1. Upon endogenous stimulation by NELL2, ROS1 activates the intracellular signaling pathway and triggers epididymal epithelial differentiation and subsequent sperm maturation (By similarity). May activate several downstream signaling pathways related to cell differentiation, proliferation, growth and survival including the PI3 kinase-mTOR signaling pathway. Mediates the phosphorylation of PTPN11, an activator of this pathway. May also phosphorylate and activate the transcription factor STAT3 to control anchorage-independent cell growth. Mediates the phosphorylation and the activation of VAV3, a guanine nucleotide exchange factor regulating cell morphology. May activate other downstream signaling proteins including AKT1, MAPK1, MAPK3, IRS1 and PLCG2. . |
Accessions | ENST00000403284.2 Q5H8Y1 ENST00000368507.8 P08922 ENST00000368508.7 H0Y3T9 |